Ah, I see what you're saying. Thanks. Wish you'd have been on the conference call.
I don't understand any focus on formal responses. IMO ttp is the rational measure for any molecule, but it has to be the hurdle for new cytostatic agents.
>> Why they are holding TTP data for randomized group? <<
Tradition. I wouldn't either. It's the right/responsibility of the clinical investigator(s) to report the data. Yes, some companies have broken that tradition in recent years. Don't remember the role of clinical investigators in reporting Maxim data, if there was one, but..... which would you prefer?.... a company that respects the investigator or one that digests the data for you?
;-(
>> However, it may not sell as well as on will hope for. <<
Wouldn't take a very large penetration of the market to make it a raging buy?
Dunno. As you know, I don't like companies once they get to this stage in development. Further, I didn't like the old spinmeister days of Frank et al. But I bought a small stake.
edit: hadn't been watching, taking the morning off..... baseball and alcohol wasting had set it..... but it's moving a bit. |
